Work

First-in-human study of BG-C9074 (B7-H4–targeting ADC) in advanced solid tumors: Dose escalation and safety expansion.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.3013

Authors: Binghe Xu, Linda R. Mileshkin, Andrew Ohyama Parsonson, Qinglei Gao, Amy Body, Tongsen Zheng, Wen Xu, Jennifer Diamond, Saana D'Alonzo, Garret Winkler, Hugh Giovinazzo, Juan Zhang, Wei Tan, Ramil Abdrashitov, Cesar Augusto Perez

Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences, Peter MacCallum Cancer Centre, Macquarie University, Tongji Hospital, Huazhong University of Science and Technology, Monash Health, Monash University, Third Affiliated Hospital of Harbin Medical University, Princess Alexandra Hospital, University of Colorado Cancer Center, University of Colorado Denver, BeOne Medicines (Switzerland), Florida Cancer Specialists & Research Institute

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162564481

Cites:

Cited by: 1

Related to: